Potential protective benefits of Schisandrin B against severe acute hepatitis in children during the COVID-19 pandemic based on a network pharmacology analysis

Aims: Reports of hepatitis in children during the coronavirus disease 2019 (COVID-19) pandemic garnered worldwide attention. The most probable culprits are adenovirus and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). At present, the optimal symptomatic treatment consists of a combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yanhua, Zhang, Lingling, Wang, Zhe, Wang, Ruoyu, Liang, Shanshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403136/
https://www.ncbi.nlm.nih.gov/pubmed/36034788
http://dx.doi.org/10.3389/fphar.2022.969709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403136/
https://www.ncbi.nlm.nih.gov/pubmed/36034788
http://dx.doi.org/10.3389/fphar.2022.969709

Ejemplares similares